Number of Shares
703,097.00
Current Holdings Value*
$189.85 Mil
% of Portfolio
1.83%
Total Estimate Gain
$103.35 Mil
% of Total Estimate Gain
62.00%

JPMorgan Mid Cap Growth Fund's Alnylam Pharmaceuticals Inc Holding Summary

As of 2025-03-31, JPMORGAN TRUST II held 703,097.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $189.85 Mil. This investment constitutes 1.83% of their stock portfolio, and JPMORGAN TRUST II now holds 0.54% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.

The initial trade took place in 2019Q3. And since then JPMorgan Mid Cap Growth Fund has made 14 purchases of ALNY, at an average price of $170.10, for a total of 980,006.00 shares. In addition, there have been 4 sales at an average price of $148.37 for 276,909.00 shares. Based on historical transaction data and ALNY's current price of $325.64, JPMorgan Mid Cap Growth Fund's estimated gain on his ALNY holdings is $103.35 Mil, reflecting a 62.00% gain to date.

JPMorgan Mid Cap Growth Fund ALNY ($325.64) Holding Chart

JPMorgan Mid Cap Growth Fund ALNY ($325.64) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1